个体光照剂量-效应曲线:如何用光传感器把’天人相应’从拼接变成实测

Written by

in

Language

Evidence level: B

过去十年关于”光照破坏月相-月经同步”的证据,全是把不同人群拼接成一条曲线;真正的剂量-效应曲线,需要同一个人戴着光传感器被纵向记录几个月——这不是设想,是今天技术已能做到的实证设计。

正文

“天人相应”被现代研究改写成了一个剂量问题:光照越多,人与月亮的同步越弱。 但细看证据会发现一个尴尬:这条”剂量-效应曲线”从不是在同一个人身上测出来的,而是把部落、乡村、城市、夜班、LED时代后的人群拼接凑出来的(PMID 33571128, 40991714, 24901274)。拼接曲线能证明”方向”,却给不出”剂量”——多少 lux、照多久、什么光谱,才让月相-月经耦合衰减一个档次?这正是#240课题指向的实证空白。

技术底座已经成熟:光传感器可以戴在手腕上测个体真实暴露。 2020年《Clocks & Sleep》测试了 GENEActiv 腕戴式设备在 LED、荧光、红外、户外等真实光照条件下的精度:输出与照度强线性相关,足以区分室内外、绘制个体光照模式;局限是 100 lux 以下精度下降(PMID 33089197)。更新的可穿戴光度计已能同时记录光通量照度与黑视素等效照度(melanopic EDI),30 秒间隔连续采样——一枚腕表就覆盖”lux×时长×光谱”的前两维,光谱维由黑视素通道量化(PMID 32248548)。测”光照剂量”无技术障碍。

褪黑素端的剂量-效应基线画得很细,起点低得惊人。 2019年《J Pineal Res》建模发现:人类褪黑素抑制与黑视素照度呈 S 形关系,约 1.5 melanopic lux 即可启动抑制,305 melanopic lux 饱和(PMID 30697806)。现代家庭睡前 3 小时平均黑视素照度 3.9-77.4 mlux,足以让 48% 的家庭产生至少 50% 的褪黑素抑制;个体差异极大——最敏感者 100% 家庭照明都造成≥50%抑制,最不敏感者 0%(PMID 32248548)。“群体平均”掩盖了真实结构,正需要个体层面纵向测量。

链条末端也有定量锚点:光照以剂量方式改变月经周期。 1978年 Dewan 给 16 名周期不规律女性在第 14 天夜间施加光照,周期变异性下降、在 29 天出现尖峰(PMID 674392);2007年 Danilenko 对照交叉试验显示卵泡期晨间 4300 lux 光照 1 周使 LH/FSH 升高、排卵周期数翻倍(PMID 17290302)。高剂量端锚点来自轮班 meta:2014年 12.3 万女性月经紊乱 OR 1.22(PMID 24901274);2023年 19.6 万人不规则月经 OR 1.30(PMID 37954014)。低剂量端同步最强、高剂量端紊乱最重——两端有人测过,中间那段个体内连续曲线是空缺。

为什么必须纵向、必须个体内测量? 其一,群体拼接无法分离混杂:轮班研究把光照与睡眠剥夺、压力捆在一起,城乡比较混入生育史、社会节奏差异;只有让同一个人在不同光照窗口间切换,才能剥离光照的独立贡献。其二,同步度需要长窗口估计:月相-月经同步是弱信号,个体层面至少需 6-12 个月经周期才能给出可靠的同步指数置信区间——这是”纵向”的数学必要性。其三,阈值与连续之争只能在个体曲线上裁决:是”低于某 lux 阈值就保留同步、超过就断崖丢失”,还是”每多 100 lux 线性衰减一点”?前者指向断点回归,后者指向连续梯度模型,两种假设给出完全不同的干预建议。

可执行的方案已经具体化。 招募 100-200 名规律周期女性,腕戴光传感器(photopic lux + melanopic EDI,30 秒采样)连续 6-12 个月;App 逐周期记录月经数据并标注月相相位;以个体同步指数(相对协调度、圆形统计 Rayleigh 检验)为结局做剂量-效应回归:夜间黑视素照度、光照时长、蓝光比例为自变量,个体为随机效应,纳入年龄、MTNR1B 基因型协变量。这个设计没有一项是新技术(PMID 33089197, 30697806)。

对”天人相应”的意义: 这条实测曲线一旦画出,就把”人与自然耦合正在被现代生活切断”从直觉变成一张可挂墙的图:横轴是”你每晚看手机时屏幕的光”,纵轴是”你的月经还能不能听见月亮”。它同时回答三个问题——保住同步的最低光照上限、光谱是否独立于强度起作用、个体敏感度差异。

证据与局限

已验证: 腕戴式光传感器可准确绘制个体光照模式(PMID 33089197);褪黑素抑制与黑视素照度呈 S 形剂量-效应关系、1.5 melanopic lux 即启动(PMID 30697806);家庭夜间照明可造成显著褪黑素抑制且个体差异巨大(PMID 32248548);光照可缩短偏长月经周期并提高排卵率(PMID 674392, 17290302);轮班与月经紊乱显著相关(PMID 24901274, 37954014)。

部分验证: 群体拼接的”光照强度→同步度递减”证据链(部落/乡村/城市/夜班/后LED时代)各段成立,但无个体内连续测量;月经追踪 App 排卵预测精度较好但记录质量参差;光传感器在 100 lux 以下精度下降、需光源类型校正。

待验证: 同一个人”光照剂量(lux×时长×光谱)→月相-月经耦合强度”的完整个体内剂量-效应曲线;耦合衰减是阈值效应还是连续递减;光谱成分(蓝光比例)在耦合衰减中的独立作用;褪黑素受体基因型对光照敏感度的个体调节。

相关阅读

证据等级: B
参考文献: PMID 33089197, PMID 30697806, PMID 32248548, PMID 674392, PMID 17290302, PMID 24901274, PMID 37954014


免责说明:本文属传统知识与科学文献的整理、对照与研究设计讨论,仅供理解与参考,不构成医疗建议,不能替代专业诊断与治疗。文中涉及的效应量、频率区间与暴露结论多为研究报告层面的推断,个体情况差异很大;如有身体不适或健康疑虑,请就医并由专业医师判断。

Individual Light Dose-Response Curve: How to Turn ‘Harmony Between Humans and Nature’ from Assembled Data into Measured Reality Using Light Sensors

Evidence level: B

Over the past decade, evidence regarding “light disrupting lunar-menstrual synchrony” has relied on assembling disparate populations into a single curve. A true dose-response curve requires longitudinal recording of an individual wearing a light sensor over several months—this is not a hypothetical scenario, but an empirically feasible design enabled by current technology.

Main Text

“Heaven-Human Correspondence” has been reframed by modern research as a dosage issue: greater light exposure weakens human-lunar synchrony. However, closer inspection reveals an awkward reality: this “dose-response curve” was never measured on a single individual but assembled by combining data from tribes, rural areas, cities, night-shift workers, and post-LED eras (PMID 33571128, 40991714, 24901274). While assembled curves can demonstrate “direction,” they fail to quantify “dosage”—specifically, how many lux, for how long, and across what spectrum are required to attenuate lunar-menstrual coupling by a specific tier? This represents the empirical gap targeted by #240.

The technical foundation is now mature: light sensors can be worn on the wrist to measure individual true exposure. A 2020 study in Clocks & Sleep tested the GENEActiv wrist-worn device under real-world lighting conditions including LED, fluorescent, infrared, and outdoor environments. The output showed a strong linear correlation with illuminance, sufficient to distinguish indoor/outdoor settings and map individual light patterns; however, accuracy declines below 100 lux (PMID 33089197). Updated wearable photometers can now simultaneously record photopic illuminance and melanopic Equivalent Daylight Illuminance (EDI), sampling continuously at 30-second intervals. A single watch covers the first two dimensions of “lux × duration × spectrum,” with the spectral dimension quantified via the melanopic channel (PMID 32248548). Measuring “light dosage” presents no technical barrier.

The baseline for the melatonin endpoint is drawn in fine detail, starting from an astonishingly low point. A 2019 model in J Pineal Res found that human melatonin suppression follows an S-shaped relationship with melanopic illuminance, with suppression initiating at approximately 1.5 melanopic lux and saturating at 305 melanopic lux (PMID 30697806). Modern average household illuminance during the three hours before sleep ranges from 3.9 to 77.4 melanopic lux, sufficient to cause at least 50% melatonin suppression in 48% of households. Individual variability is extreme—suppression ≥50% occurs in 100% of households for the most sensitive individuals, but in 0% for the least sensitive (PMID 32248548). “Population averages” obscure the true structure, necessitating longitudinal measurement at the individual level.

There are also quantitative anchors at the chain’s end: light alters menstrual cycles in a dosage-dependent manner. In 1978, Dewan applied nighttime light to 16 women with irregular cycles on day 14, resulting in reduced cycle variability and a peak at day 29 (PMID 674392). A 2007 crossover trial by Danilenko showed that one week of morning 4300 lux exposure during the follicular phase doubled LH/FSH levels and the number of ovulatory cycles (PMID 17290302). High-dose anchors come from shift work meta-analyses: a 2014 meta-analysis reported an odds ratio of 1.22 for menstrual irregularity in 123,000 women (PMID 24901274); a 2023 study found an OR of 1.30 for irregular menstruation in 196,000 women (PMID 37954014). Synchrony is strongest at low doses, while disruption is most severe at high doses—both extremes have been measured, leaving the individual continuous curve in the middle unexplored.

Why longitudinal and within-individual measurement is mandatory: First, assembled groups cannot disentangle confounders: shift work studies bundle light with sleep deprivation and stress; rural-urban comparisons conflate reproductive history and social rhythm differences. Only by switching the same individual across different light windows can the independent contribution of light be isolated. Second, synchrony requires long-window estimation: lunar-menstrual synchrony is a weak signal; at the individual level, at least 6–12 menstrual cycles are needed to establish a reliable confidence interval for the synchrony index—this is a mathematical necessity for “longitudinal” design. Third, the threshold vs. continuous debate can only be adjudicated on individual curves: is it a step-function where synchrony is preserved below a certain lux threshold but lost abruptly above it, or does it show linear attenuation for every additional 100 lux? The former points to breakpoint regression, the latter to continuous gradient models; both hypotheses yield vastly different intervention recommendations.

An executable protocol is now concrete. Recruit 100–200 women with regular cycles; wear light sensors (photopic lux + melanopic EDI, 30-second sampling) continuously for 6–12 months. The app records menstrual data cycle-by-cycle and annotates lunar phase. Perform dose-response regression using individual synchrony indices (relative coordination, Rayleigh test for circular statistics) as the outcome: nighttime melanopic illuminance, light duration, and blue light proportion as independent variables, with individual as a random effect, controlling for age and MTNR1B genotype. Not a single element of this design relies on new technology (PMID 33089197, 30697806).

Significance for “Heaven-Human Correspondence”: Once this measured curve is plotted, the intuition that “coupling with nature is being severed by modern life” transforms into a wall-chartable figure: the x-axis represents “the light on your screen when you look at your phone each night,” and the y-axis represents “whether your menstruation can still ‘hear’ the moon.” It simultaneously answers three questions: the minimum light exposure ceiling required to preserve synchrony, whether spectral composition acts independently of intensity, and individual sensitivity differences.

Evidence and Limitations

Verified: Wrist-worn light sensors accurately map individual light patterns (PMID 33089197); melatonin suppression follows an S-shaped dose-response relationship with melanopic illuminance, initiating at ~1.5 melanopic lux (PMID 30697806); household nighttime lighting causes significant melatonin suppression with high individual variability (PMID 32248548); light shortens prolonged menstrual cycles and increases ovulation rates (PMID 674392, 17290302); shift work is significantly associated with menstrual irregularity (PMID 24901274, 37954014).

Partially Verified: The assembled evidence chain showing “light intensity → decreasing synchrony” holds for each segment (tribe/rural/city/night-shift/post-LED), but lacks within-individual continuous measurement; menstrual tracking apps show good ovulation prediction accuracy but variable data quality; light sensor accuracy declines below 100 lux and requires light source type correction.

To Be Verified: The complete within-individual dose-response curve linking “light dosage (lux × duration × spectrum) → lunar-menstrual coupling intensity” in the same person; whether coupling attenuation is a threshold effect or continuous decrement; the independent role of spectral composition (blue light ratio) in coupling attenuation; the moderating role of melatonin receptor genotype on individual light sensitivity.

Related Reading

Evidence Level: B
References: PMID 33089197, PMID 30697806, PMID 32248548, PMID 674392, PMID 17290302, PMID 24901274, PMID 37954014


Disclaimer: This article compiles traditional knowledge and scientific literature for comparison and research-design discussion only. It is not medical advice and cannot replace professional diagnosis or treatment. Effect sizes, frequency ranges and exposure conclusions cited here are largely inferences at the research-report level, and individual circumstances vary widely. If you have any discomfort or health concerns, please consult a physician.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *